MAGNI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 3.554
AS - Asia 3.529
EU - Europa 3.489
SA - Sud America 373
AF - Africa 58
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.031
Nazione #
US - Stati Uniti d'America 3.420
CN - Cina 1.389
SG - Singapore 879
IT - Italia 804
GB - Regno Unito 745
RU - Federazione Russa 549
DE - Germania 489
BR - Brasile 303
HK - Hong Kong 276
BD - Bangladesh 203
SE - Svezia 178
VN - Vietnam 176
FR - Francia 154
IN - India 148
TR - Turchia 109
JP - Giappone 98
FI - Finlandia 91
DK - Danimarca 82
KR - Corea 82
IE - Irlanda 68
NL - Olanda 68
CA - Canada 64
UA - Ucraina 54
MX - Messico 50
PL - Polonia 44
ES - Italia 42
ID - Indonesia 41
AU - Australia 22
EU - Europa 20
IR - Iran 20
AR - Argentina 16
BE - Belgio 16
IQ - Iraq 16
AT - Austria 15
CO - Colombia 14
TW - Taiwan 14
CI - Costa d'Avorio 13
GR - Grecia 13
HU - Ungheria 13
TH - Thailandia 12
PT - Portogallo 11
CH - Svizzera 10
UZ - Uzbekistan 10
CL - Cile 9
EC - Ecuador 9
PE - Perù 9
IL - Israele 8
ZA - Sudafrica 8
LT - Lituania 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
EG - Egitto 6
PK - Pakistan 6
RO - Romania 6
KZ - Kazakistan 5
MA - Marocco 5
NZ - Nuova Zelanda 5
PH - Filippine 5
RS - Serbia 5
SI - Slovenia 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
JO - Giordania 4
TN - Tunisia 4
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
NG - Nigeria 3
SC - Seychelles 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GE - Georgia 2
GT - Guatemala 2
LK - Sri Lanka 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
TJ - Tagikistan 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
BW - Botswana 1
BZ - Belize 1
CU - Cuba 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 11.038
Città #
Southend 541
Singapore 521
Milan 304
Ashburn 301
Hong Kong 245
San Jose 238
Beijing 200
Santa Clara 188
Frankfurt am Main 168
Chandler 157
Fairfield 142
Seattle 121
Council Bluffs 108
Wilmington 106
Sunnyvale 100
Princeton 94
Dallas 92
Los Angeles 92
Redwood City 91
Houston 86
Mountain View 86
New York 79
Shanghai 79
Nanjing 68
Dublin 66
Ann Arbor 59
Guangzhou 54
Ho Chi Minh City 54
Hefei 53
Cambridge 50
Grafing 50
Hanoi 50
Woodbridge 48
Istanbul 46
Helsinki 44
Lauterbourg 44
Moscow 44
Dearborn 43
Bengaluru 42
Phoenix 41
Tokyo 37
Boardman 36
Buffalo 36
Redmond 36
Changsha 35
Des Moines 35
Hanover 35
Berlin 33
Shenyang 33
Jinan 31
Nanchang 31
Hangzhou 29
Jakarta 29
Warsaw 29
Chicago 28
Rome 28
Chengdu 27
Columbus 27
Tianjin 27
Wuhan 25
Falls Church 24
Munich 24
London 23
Evanston 22
Shenzhen 22
Somerville 21
The Dalles 21
Medford 20
São Paulo 20
Chongqing 18
Hebei 17
Cangzhou 16
Odernheim 16
Toronto 16
Kiez 14
Lanzhou 14
Abidjan 13
Bogotá 13
Brussels 13
Fuzhou 13
Naples 12
Ningbo 12
Andover 11
Bari 11
Chapecó 11
Mexico City 11
Monza 11
Nuremberg 11
Sakarya 11
Seoul 11
Zhengzhou 11
Atlanta 10
Boston 10
Manchester 10
San Diego 10
Taipei 10
Xian 10
Aarhus 9
Athens 9
Brooklyn 9
Totale 6.192
Nome #
Tackling chronic pain and inflammation through the purinergic system 1.010
Basal astrocyte and microglia activation in the central nervous system of Familial Hemiplegic Migraine Type I mice 566
Flavonoids bridging the gut and the brain: intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration 449
Glial cell activation and altered metabolic profile in the spinal-trigeminal axis in a rat model of multiple sclerosis associated with the development of trigeminal sensitization 388
The role of adenosine and P2Y receptors expressed by multiple cell types in pain transmission 376
P2Y purinergic receptors: new targets for analgesic and antimigraine drugs 327
Dipeptidyl peptidase-4 inhibitors and sulfonylureas prevent the progressive impairment of the nigrostriatal dopaminergic system induced by diabetes during aging 315
Temporomandibular joint inflammation activates glial and immune cells in both the trigeminal ganglia and in the spinal trigeminal nucleus 310
Corn (ZEA MAYS L). extracts as source of active compounds with promising effects in reducing trigeminal pain through microbiota modulation 300
Purple Corn Extract as Anti-allodynic Treatment for Trigeminal Pain : Role of Microglia 285
Studies of familial hemiplegic migraine transgenic mouse models and patients to investigate the crosstalk between sensory neurons and neuroinflammatory cells in trigeminal ganglia in relation to migraine pain 248
Neuroinflammation in osteoarthritis: From pain to mood disorders 221
Adult neurogenesis in the subventricular zone: studies on the role of purinergic signalling by the neurosphere assay 217
Modulation of glial P2Y receptors by algogenic mediators in the trigeminal ganglion: a role for the purinergic system in the mechanism of action of known anti-migraine drugs? 217
Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier 213
Nucleotide receptors in trigeminal satellite glial cells as new targets for the pharmacological control of migraine pain: in vitro and in vivo studies 212
Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model 208
Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death 206
P2Y2 receptor antagonists as anti-allodynic agents in acute and sub-chronic trigeminal sensitization: role of satellite glial cells 203
The purinergic system cooperates with the algogenic factors bradykinin and CGRP in modulating neuron/glia communication in mouse trigeminal ganglia from wild type and R192Q Cav2.1 knock-in mice: implications for basic mechanisms of migraine pain 201
The Purinergic System and Glial Cells : Emerging Costars in Nociception 194
Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine 191
Activation of glial cells in the cervical spinal cord and in the trigeminal ganglion following induction of inflammatory pain 191
Purinergic neuron/glia communication in mouse trigeminal ganglia and its crosstalk with known algogenic mediators: implications for basic mechanisms of migraine pain 190
Glial cell activation in the spinal-trigeminal system in vivo : implications for basic mechanisms of pain transmission 188
Prevention of motor relapses and associated trigeminal pain in experimental autoimmune encephalomyelitis by reducing neuroinflammation with a purple corn extract enriched in anthocyanins 187
Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 Knock-in mice: implications for basic mechanisms of migraine pain 186
Role of the purinergic system in controlling blood-brain barrier functions : focus on ATP-metabolizing enzymes 182
Lipoic-Based TRPA1/TRPV1 antagonist to treat orofacial pain 181
Purinergic neuron/glia communication in the spinal-trigeminal system in vitro and in vivo: implications for basic mechanisms of pain transmission 178
Adenosine Signaling in Autoimmune Disorders 174
Role of the purinergic system in controlling blood-brain barrier functions upon ischemic conditions: focus on ATP-metabolizing enzymes 173
Role of ATP and ATP-metabolizing enzymes in neuroreparative processes after hypoxic-ischemic injury in rodent organotypic brain slices 171
Nucleotide receptors in trigeminal satellite glial cells as new targets for the pharmacological control of migraine pain: in vitro and in vivo studies 171
Crosstalk between the purinergic system and known algogenic mediators in mouse trigeminal ganglia : implications for basic mechanisms of migraine pain 170
Crosstalk between sensory neurons and neuroinflammatory cells in trigeminal ganglia in relation to migraine pain 169
Role of ATP and ATP-metabolizing enzymes in neuroreparative processes after hypoxic-ischemic injury in rodent organotypic brain slices 166
Role of the purinergic system in controlling blood-brain barrier functions : Focus on ATP-metabolizing enzymes 158
Purinergic P2Y(2) receptors on satellite glial cells as new potential targets for the pharmacological control of trigeminal sensitization 157
Il mais pigmentato quale potenziale approccio nella modulazione della sintomatologia associata alla sclerosi multipla : caratterizzazione e dati preliminari in vivo 151
Role of the purinergic system in controlling blood-brain barrier functions upon ischemic conditions: focus on ATP-metabolizing enzymes 144
Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death 144
Purines in Pain as a Gliopathy 144
Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies 139
MODULATION OF GLIAL P2Y RECEPTORS BY ALGOGENIC MEDIATORS IN THE TRIGEMINAL GANGLIA: A ROLE FOR THE PURINERGIC SYSTEM IN THE MECHANISM OF ACTION OF KNOWN ANTI-MIGRAINE DRUGS? 139
Modulation of Glial Cell Functions by the Gut–Brain Axis: A Role in Neurodegenerative Disorders and Pain Transmission 123
P2Y receptors in trigeminal pain 117
BBB and the purinergic system 115
Adult neurogenesis in the subventricular zone: studies on the role of purinergic signalling by the neurosphere assay 112
Purinergic neuron/glia communication in trigeminal ganglia : interactions with other algogens and implications for migraine pain 106
Increased response to glutamate in small diameter dorsal root ganglion neurons after sciatic nerve injury 78
Purple Corn Anthocyanins Prevent the Progression of Multiple Sclerosis-Associated Trigeminal Pain 33
Purple corn anthocyanins as a nutraceutical approach to control the progression of multiple sclerosis and associated trigeminal pain: role of glial cells 29
Purple corn anthocyanins protect from the progression of multiple sclerosis and its associated symptoms: A role for glial purinergic receptors? 29
Totale 11.452
Categoria #
all - tutte 31.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 0 0 0 0 0 39
2021/2022704 60 49 26 56 65 41 79 52 51 47 59 119
2022/2023773 84 40 63 65 82 138 47 44 105 20 39 46
2023/2024871 27 50 67 111 191 71 38 52 25 63 106 70
2024/20251.627 65 169 43 131 194 73 89 151 89 106 165 352
2025/20263.367 281 213 310 260 320 213 420 174 384 216 353 223
Totale 11.452